Article Information
History
- March 31, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marine Peyneau1,2,
- Vanessa Granger1,2,
- Paul-Henri Wicky3,4,
- Dounia Khelifi-Touhami1,
- Jean-François Timsit3,4,
- François-Xavier Lescure4,5,
- Yazdan Yazdanpanah4,5,
- Alexy Tran-Dihn6,7,
- Philippe Montravers6,7,
- Renato C. Monteiro8,9,
- Sylvie Chollet-Martin1,2,
- Margarita Hurtado-Nedelec8,9 and
- Luc de Chaisemartin1,2,*
- 1AP-HP, Bichat Hospital, Autoimmunity and Hypersensitivity Laboratory; Paris, France
- 2Université Paris-Saclay, INSERM UMR 996, “Inflammation, Microbiome and Immunosurveillance”, Faculty of Pharmacy; 92290 Châtenay-Malabry, France
- 3AP-HP, Bichat hospital Medial and infectious diseases ICU (MI2); Paris France
- 4IAME Université de Paris, Inserm U 1137; Paris France
- 5AP-HP, Hôpital Bichat, Infectious Diseases Department ; Paris, France
- 6AP-HP, Bichat Hospital, Département d’Anesthésie-Réanimation, DMU PARABOL, Université de Paris; Paris France
- 7INSERM UMR 1152 – ANR10-LABX-17; Paris, France
- 8U1149, CNRS ERL8252, Center for Research on Inflammation (CRI), Inflamex Laboratory of Excellence; Paris, France
- 9APHP, Bichat Hospital, Immunological Dysfunction Laboratory, Paris, France
- ↵*Corresponding author. Email: luc.de-chaisemartin{at}aphp.fr